Salute e Benessere

Monthly information related to total number of voting rights and shares…

Article 223-16 of general regulation of French Autorité des Marchés FinanciersListing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)Website : www.phaxiam.com DateTotal of shares composing the share capitalTotal of brut(1)voting rightsTotal of net(2)voting rights December 31, 20236 075 1056 226 9826 226 733January 31, 20246 075 1056 227 0026 226 753February 29, 20246 075 1056...
Nasdaq GlobeNewswire
05/06/2024

Veterinary Practice Management Software Market to be Worth $674.5 Million by…

Veterinarians use veterinary practice management software to manage patient information, treatment planning, and scheduling, as well as back-office functions, such as accounting. This type of software helps veterinary clinics with patient diagnosis and treatment management and allows nurses or technicians to deliver treatments efficiently. Administrative personnel use veterinary practice management software to manage patient communications, influx, and payments. More advanced veterinary practice…
PR Newswire
05/06/2024

Ambulatory EHR Market to be Worth $7.84 billion by 2031 - Exclusive Report by…

Ambulatory electronic health record (EHR) software is designed for outpatient care settings, enabling medical professionals to access a patient's complete medical history stored in an electronic format. This data includes records of treatments and procedures conducted outside of hospital admissions. Ambulatory EHR systems facilitate easier monitoring of a patient's medical history and long-term care by physicians. Through this software, physicians can gather detailed and relevant information…
PR Newswire
05/06/2024

Custom Antibody Market Worth $901 million | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301 Browse in-depth TOC on "Custom Antibody Market" 472 - Tables 52 - Figures 395 - Pages Custom Antibody Market Scope: The antibody development segment accounted for the largest share by service segment in the custom antibody market in 2023. By service, the custom...
PR Newswire
05/06/2024

Hearth Market worth $13.4 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Hearth Market" Browse in-depth TOC on "Hearth Market" 120 – Tables 65 – Figures 220 – Pages Hearth Market Report Scope: Inserts as a product to grow at the highest CAGR in the hearth market during the forecast period. Fireplaces dominated the market, capturing a major share among hearth appliances, underscoring their enduring popularity and historical significance as one of the oldest types ofhearthproducts. The segment of fireplace inserts is...
PR Newswire
05/06/2024

ILIKOS Consulting Group and Phoenix Clinical Research Announce Strategic…

Phoenix Clinical Research: an ambassador for the MENA & GCC regions Phoenix Clinical Research: an ambassador for the MENA & GCC regions Boasting significant expertise and meaningful relationships across numerous countries,Phoenixoffers a unique value proposition combining Patient access to a wide range of chronic, acute and rare indications with high quality.Phoenixworks closely with study Sponsors across all phases of development to mitigate risk, develop and establish...
PR Newswire
05/06/2024

FDA and CluePoints Sign New 3 Year Cooperative Research and Development…

To discover signals of suspected misbehavior, the FDA and other authorities rely on site inspections and whistleblowers. Due to the large number of product filings, the FDA can only inspect a small percentage of clinical trial sites. The determination of which sites to inspect can involve FDA inspectors' judgement and experiences, suggestions by clinical and statistical reviewers, and CDER's risk-based site selection tool. Under the original CRADA between FDA and CluePoints, software was…
PR Newswire
05/06/2024

Introducing NOYZ, A Modern Fragrance Brand Disrupting Industry Standards of…

Developed by renowned Robertet perfumer, Jerome Epinette, the collection comprises four expressive, long lasting fragrances. NOYZ is inspired by its community and encourages them to speak and feel their truth wholeheartedly. Each fine fragrance is genderless and each scent's name is inspired by relatable experiences and authentic storytelling. NOYZ champions building a fragrance wardrobe, switching up scents based on every mood, layering and mixing it up to create something that is unique to the…
PR Newswire
05/06/2024

IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with…

The April 1st partial legalization of cannabis in Germany, has potentially paved the way for tremendous category growth. With a population of over 83 million, Germany has more than double the population of California, which had a cannabis industry of about $5 billion in 2023.[1] Until the social clubs are up and running, the only legal way to buy cannabis in Germany is with a prescription, driving significant growth in the Medical Market. TheApril 1stpartial legalization of cannabis in...
PR Newswire
05/06/2024

Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts

Appoints David Sutherland, CPA, as Vice President of Finance and Controller "The relocation of our corporate headquarters to Boston solidifies our commitment to building the company in the U.S. and positions us at the heart of a thriving biotechnology hub with world-class talent,” said Tim Pearson, Chief Executive Officer of Carrick Therapeutics.Carrick also announced the appointment of David Sutherland, CPA, to the position of Vice President of Finance and Controller. Mr. Sutherland has...
Nasdaq GlobeNewswire
05/06/2024

Ashfield Event Experiences and WRG combine to create the new global experiential…

The types of experiences Emota creates include medical congresses and conventions, brand activations and experiences, advisory boards, investigator meetings, roadshows, product launches, sales meetings, public events, symposia, incentive trips, training and educational programmes among others. The types of experiences Emota creates include medical congresses and conventions, brand activations and experiences, advisory boards, investigator meetings, roadshows, product launches, sales meetings,...
PR Newswire
05/06/2024

Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating…

Interim CEO employment contract consists solely of equity compensation Samir R. Patel, M.D., increases ownership to 14.2% with $1.25m investment in recent private placement BOSTON and LONDON, June05, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory diseases, in follow up to the May 1 stannouncement that Samir R. Patel, M.D., has assumed the role of Interim President & CEO,...
Nasdaq GlobeNewswire
05/06/2024

Crisis24 Combines Elite Concierge Medical Practice and Personal Protection…

The Global Medical Concierge Practice is spearheaded by an industry-recognized team responsible for managing the health and safety of U.S. Presidents and top international business leaders. This highly personalized, comprehensive offering enables the world's most influential and prominent people to mitigate personal risks and, most importantly, ensure their medical preparedness matches their security readiness. The Global Medical Concierge Practice is spearheaded by an industry-recognized…
PR Newswire
05/06/2024

Rising Obesity and Inactivity Drive Global Obesity-Diabetes Drug Market to USD…

Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19677 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19677 Therapeutic drugs have a remarkable role in the effective management of obesity-diabetes. It aids obesity-diabetic patients in controlling blood sugar levels and preventing further complications in diseased...
PR Newswire
05/06/2024

Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031-…

Exosomes, a form of nanoparticle also referred to as small extracellular vesicles, are gathering attention as potential novel therapeutics for a variety of diseases due to their capacity to deliver genetic or bioactive molecules to recipient cells. Exosomes have demonstrated potential in diagnosing, monitoring, and treating various conditions, including certain cancers, cardiopulmonary diseases, and neurodegenerative disorders. Exosomes, a form of nanoparticle also referred to as small...
PR Newswire
05/06/2024

Vivet Therapeutics Presents Interim Data from its Phase 1/2 GATEWAY Trial for…

PARIS, June 5, 2024 /PRNewswire/ -- Vivet Therapeutics ("Vivet"), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, today announces the presentation of interim data on its international Phase 1/2 GATEWAY trial, evaluating the safety, pharmacodynamics, and efficacy of its lead program, VTX-801 for the treatment of Wilson Disease (WD) at the EASL Congress 2024, held in Milan, Italy. PARIS,June 5…
PR Newswire
05/06/2024

Paroxysmal Supraventricular Tachycardia Market to Show Immense Growth During the…

Key Takeaways from the Paroxysmal Supraventricular Tachycardia Market Report Key Takeaways from the Paroxysmal Supraventricular Tachycardia Market Report Discover which therapies are expected to grab the major paroxysmal supraventricular tachycardia market share @Paroxysmal Supraventricular Tachycardia Market Report Paroxysmal Supraventricular Tachycardia Overview Paroxysmal supraventricular tachycardia (PSVT) is an abnormal heart rhythm that begins and ends abruptly...
PR Newswire
05/06/2024

Curium Adds the Institut Laue-Langevin Reactor to Global Irradiation Portfolio…

This new partnership with the ILL will add additional security of supply while bringing a high-flux reactor within the Curium irradiation reactor landscape. The agreement announced today follows Curium's announcement on 29th May 2024 to extend its irradiation partnership with NRG I PALLAS in the Netherlands. Curium's Lu-177 program will benefit more than 100,000 critically ill patients worldwide over the next five years. Ciril Faia, CEO SPECT Europe for Curium commented, “With the...
Nasdaq GlobeNewswire
05/06/2024

Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from…

Jixing Wang, President at Dalton, commented: "Due to increasing customer demand, we needed to further enhance our competencies in speed, quality and flexibility. Having maximised our capacity in aseptic powder fill/finish, we sought innovative technology to support our growth. This investment will reinforce Dalton's market position as a leading partner in aseptic powder filling." Jixing Wang, President at Dalton, commented: "Due to increasing customer demand, we needed to further…
PR Newswire
05/06/2024

Coway Launches Affordable, Cylindrical Model for Small Spaces: The Airmega 100

Coway is introducing the Airmega 100 for Europeans seeking protection against hay fever and allergy season. It is reported that hay fever season starts earlier and lasts longer over the last 20 years with climate change. This calls for the need for effective protective measures against pollen and allergies. The Airmega 100 has been meticulously designed with features that promote healthy air and rejuvenating rest amid hay fever season. Coway is introducing the Airmega 100 for Europeans…
PR Newswire
05/06/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2024

Accumulated revenue for January – May 2024 increased by 21 % to SEK 802.2 (661.8) million. Accumulated revenue for January –May 2024increased by 21 % toSEK 802.2(661.8) million. Revenues were distributed as follows: Countries in regions: -The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden- Central Europe :Austria,Germany,Switzerland- East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania-South &West Europe :...
PR Newswire
05/06/2024

Department of Health - Abu Dhabi and Opus Genetics Announce Collaboration to…

In the presence of H.E. Mansoor Al Mansoori, Chairman of DoH, and Ben Yerxa, Ph.D., Chief Executive Officer (CEO) of Opus Genetics, the MoU was signed by Dr Asma Al Mannaei, the Executive Director of the Research and Innovation Centre at DoH and Dr. Yerxa. In the presence of H.E.Mansoor Al Mansoori, Chairman of DoH, andBen Yerxa, Ph.D., Chief Executive Officer (CEO) of Opus Genetics, the MoU was signed by DrAsma Al Mannaei, the Executive Director of the Research and Innovation Centre...
PR Newswire
05/06/2024

Reusable Water Bottle Market to Reach $13,549.0 Million, Globally, by 2032 at…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1977 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1977 Prime determinants of growth The growth of the global reusable water bottle market is driven by factors such as a rise in demand for sustainable products and rise in environmental awareness among consumers. However, high costs and availability of alternatives restrict the market...
PR Newswire
05/06/2024

Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential…

"We are looking forward to initiating the first-in-human trial of PFL-002/VERT-002 later this year. We are confident that this new drug holds significant promise, as a novel therapeutic option with a differentiated mechanism of action, for patients facing MET-altered solid tumors, including NSCLC" said Francesco Hofmann, Head of Research and Development for Medical Care at Pierre Fabre Laboratories. "We are looking forward to initiating the first-in-human trial of PFL-002/VERT-002…
PR Newswire
05/06/2024
Altri  Comunicati